WEKO3
アイテム
{"_buckets": {"deposit": "048ce32a-101d-4ed1-a4fb-df358f9cbcfb"}, "_deposit": {"created_by": 1, "id": "71357", "owners": [1], "pid": {"revision_id": 0, "type": "depid", "value": "71357"}, "status": "published"}, "_oai": {"id": "oai:repo.qst.go.jp:00071357", "sets": ["28"]}, "author_link": ["701629", "701626", "701628", "701627", "701625", "701630", "701631", "701624"], "item_10005_date_7": {"attribute_name": "発表年月日", "attribute_value_mlt": [{"subitem_date_issued_datetime": "2008-06-03", "subitem_date_issued_type": "Issued"}]}, "item_10005_description_5": {"attribute_name": "抄録", "attribute_value_mlt": [{"subitem_description": "Background: Carbon ion radiotherapy showed promising clinical outcomes in 57 patients with bone and STS during the phase I study (Kamada, JCO 22 4466-4471, 2002). This phase II study was planned thereafter. \nMethods: From April 2000 to February 2007, 301 lesions of 282 patients with bone and STS not suited for surgical resection were enrolled in this phase II study. A total dose of 64.0 GyE in 16 fractions over 4 weeks was indicated for 15 lesions, that of 70.4 GyE for 276 and remaining 10 receiving 73.6 GyE. Mean age was 52 yrs, (range 12-85); site of origin was the pelvis in 74%, spine or para-spinous soft tissue in 20%, extremities in 5%: bone primary was in 78% and soft tissue in 22%; pathologic subtype in bone sarcoma was chordoma in 42%, chondrosarcoma in 21%, osteosarcoma in 21%; pathologic subtype in STS was MFH in 23%, MPNST in 21%, synovial sarcoma in 13%. \nResults: The 3- and 5-year overall actuarial survival rates were 68% (95% Cl, 61%-75%) and 52% (95% C1, 43%-61%), respectively, and the actuarial overall local control rates were 85% (95% C1, 80%- 90%), and 81% (95\u0027%C1, 74%-88%) at 3 years and 5 years of follow-up, respectively. Overall toxicity was acceptable, with 2% skin/soft tissue late G3/4 toxicity. \nConclusions: Carbon ion radiotherapy shows a substantial local control in the patients with bone and soft tissue sarcomas not suited for surgical resection with acceptable morbidity.", "subitem_description_type": "Abstract"}]}, "item_10005_description_6": {"attribute_name": "会議概要(会議名, 開催地, 会期, 主催者等)", "attribute_value_mlt": [{"subitem_description": "44th ASCO Annual Meeting", "subitem_description_type": "Other"}]}, "item_access_right": {"attribute_name": "アクセス権", "attribute_value_mlt": [{"subitem_access_right": "metadata only access", "subitem_access_right_uri": "http://purl.org/coar/access_right/c_14cb"}]}, "item_creator": {"attribute_name": "著者", "attribute_type": "creator", "attribute_value_mlt": [{"creatorNames": [{"creatorName": "Kamada, Tadashi"}], "nameIdentifiers": [{"nameIdentifier": "701624", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Imai, Reiko"}], "nameIdentifiers": [{"nameIdentifier": "701625", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Tsujii, Hirohiko"}], "nameIdentifiers": [{"nameIdentifier": "701626", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Serizawa, Itsuko"}], "nameIdentifiers": [{"nameIdentifier": "701627", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "鎌田 正", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "701628", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "今井 礼子", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "701629", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "辻井 博彦", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "701630", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "芹澤 慈子", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "701631", "nameIdentifierScheme": "WEKO"}]}]}, "item_language": {"attribute_name": "言語", "attribute_value_mlt": [{"subitem_language": "eng"}]}, "item_resource_type": {"attribute_name": "資源タイプ", "attribute_value_mlt": [{"resourcetype": "conference object", "resourceuri": "http://purl.org/coar/resource_type/c_c94f"}]}, "item_title": "Carbon Ion Radiotherapy for Bone and Soft Tissue Sarcomas", "item_titles": {"attribute_name": "タイトル", "attribute_value_mlt": [{"subitem_title": "Carbon Ion Radiotherapy for Bone and Soft Tissue Sarcomas"}]}, "item_type_id": "10005", "owner": "1", "path": ["28"], "permalink_uri": "https://repo.qst.go.jp/records/71357", "pubdate": {"attribute_name": "公開日", "attribute_value": "2013-11-14"}, "publish_date": "2013-11-14", "publish_status": "0", "recid": "71357", "relation": {}, "relation_version_is_last": true, "title": ["Carbon Ion Radiotherapy for Bone and Soft Tissue Sarcomas"], "weko_shared_id": -1}
Carbon Ion Radiotherapy for Bone and Soft Tissue Sarcomas
https://repo.qst.go.jp/records/71357
https://repo.qst.go.jp/records/71357e5f4b2ac-f90f-4db0-aa55-e083da5d2692
Item type | 会議発表用資料 / Presentation(1) | |||||
---|---|---|---|---|---|---|
公開日 | 2013-11-14 | |||||
タイトル | ||||||
タイトル | Carbon Ion Radiotherapy for Bone and Soft Tissue Sarcomas | |||||
言語 | ||||||
言語 | eng | |||||
資源タイプ | ||||||
資源タイプ識別子 | http://purl.org/coar/resource_type/c_c94f | |||||
資源タイプ | conference object | |||||
アクセス権 | ||||||
アクセス権 | metadata only access | |||||
アクセス権URI | http://purl.org/coar/access_right/c_14cb | |||||
著者 |
Kamada, Tadashi
× Kamada, Tadashi× Imai, Reiko× Tsujii, Hirohiko× Serizawa, Itsuko× 鎌田 正× 今井 礼子× 辻井 博彦× 芹澤 慈子 |
|||||
抄録 | ||||||
内容記述タイプ | Abstract | |||||
内容記述 | Background: Carbon ion radiotherapy showed promising clinical outcomes in 57 patients with bone and STS during the phase I study (Kamada, JCO 22 4466-4471, 2002). This phase II study was planned thereafter. Methods: From April 2000 to February 2007, 301 lesions of 282 patients with bone and STS not suited for surgical resection were enrolled in this phase II study. A total dose of 64.0 GyE in 16 fractions over 4 weeks was indicated for 15 lesions, that of 70.4 GyE for 276 and remaining 10 receiving 73.6 GyE. Mean age was 52 yrs, (range 12-85); site of origin was the pelvis in 74%, spine or para-spinous soft tissue in 20%, extremities in 5%: bone primary was in 78% and soft tissue in 22%; pathologic subtype in bone sarcoma was chordoma in 42%, chondrosarcoma in 21%, osteosarcoma in 21%; pathologic subtype in STS was MFH in 23%, MPNST in 21%, synovial sarcoma in 13%. Results: The 3- and 5-year overall actuarial survival rates were 68% (95% Cl, 61%-75%) and 52% (95% C1, 43%-61%), respectively, and the actuarial overall local control rates were 85% (95% C1, 80%- 90%), and 81% (95'%C1, 74%-88%) at 3 years and 5 years of follow-up, respectively. Overall toxicity was acceptable, with 2% skin/soft tissue late G3/4 toxicity. Conclusions: Carbon ion radiotherapy shows a substantial local control in the patients with bone and soft tissue sarcomas not suited for surgical resection with acceptable morbidity. |
|||||
会議概要(会議名, 開催地, 会期, 主催者等) | ||||||
内容記述タイプ | Other | |||||
内容記述 | 44th ASCO Annual Meeting | |||||
発表年月日 | ||||||
日付 | 2008-06-03 | |||||
日付タイプ | Issued |